99-13963. Oncologic Drugs Advisory Committee; Amendment of Notice  

  • [Federal Register Volume 64, Number 104 (Tuesday, June 1, 1999)]
    [Notices]
    [Pages 29325-29326]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-13963]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    
    
    Oncologic Drugs Advisory Committee; Amendment of Notice
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing an 
    amendment to the notice of meeting of the Oncologic Drugs Advisory 
    Committee. This meeting was announced in the Federal Register of May 
    20, 1999 (64 FR 27581). The meeting will be open to the public. This 
    amendment is being made to change the meeting starting time and the 
    procedures paragraph and to cancel the closed session.
    
    FOR FURTHER INFORMATION CONTACT: Karen M. Templeton-Somers, Center for 
    Drug Evaluation and Research (HFD-21), Food and Drug Administration, 
    5600 Fishers Lane, Rockville, MD 20857, 301-827-7001, or FDA Advisory 
    Committee Information Line, 1-800-741-8138 (301-443-0572 in the 
    Washington, DC area), code 12542. Please call the Information Line for 
    up-to-date information on this meeting.
    SUPPLEMENTARY INFORMATION: In the Federal Register of May 20, 1999 (64 
    FR 27581), FDA announced that a meeting of Oncologic Drugs Advisory 
    Committee would be held on June 7 and 8, 1999. On page 27581, in the 
    third column, the ``Date and Time'' and ``Procedure'' portions are 
    amended and on page 27582, in the first column, the ``Closed Committee 
    Deliberations'' portion is removed to read as follows:
        Date and Time: The meeting will be held on June 7, 1999, 9:30 a.m. 
    to 5:30 p.m. and June 8, 1999, 8 a.m. to 5:30 p.m.
        Procedure: Interested persons may present data, information, or 
    views, orally or in writing, on issues pending before the committee. 
    Written submissions may be made to the contact person by May 28, 1999. 
    Oral presentations from the public will be scheduled between 
    approximately 9:45 a.m. and 10:15 a.m. and 1:45 p.m. and 2 p.m. on June 
    7, 1999, and between approximately 8:15 a.m. and 8:45 a.m.
    
    [[Page 29326]]
    
    on June 8, 1999. Time allotted for each presentation may be limited. 
    Those desiring to make formal oral presentations should notify the 
    contact person before May 28, 1999, and submit a brief statement of the 
    general nature of the evidence or arguments they wish to present, the 
    names and addresses of proposed participants, and an indication of the 
    approximate time requested to make their presentation. After the 
    scientific presentations, a 15-minute open public session will be 
    conducted for interested persons who have submitted their request to 
    speak by May 28, 1999, to address issues specific to the submission or 
    topic before the committee.
    
        Dated: May 26, 1999.
    Michael A. Friedman,
    Deputy Commissioner for Operations.
    [FR Doc. 99-13963 Filed 5-27-99; 4:50 pm]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
06/01/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-13963
Pages:
29325-29326 (2 pages)
PDF File:
99-13963.pdf